Hybrid VP of Metabolic Diseases and/or Immunology and inflammation bei Sygnature discovery limited
Sygnature discovery limited · Montréal, Vereinigte Staaten Von Amerika · Hybrid
- Optionales Büro in Montréal
Background
Sygnature Discovery is a world-leading integrated drug discovery Contract Research Organisation based in the UK and Canada with its headquarters in Nottingham and additional facilities in Alderley Park, Macclesfield, Glasgow, Montreal and Quebec City. Its staff of over 1,000, which includes 900 scientists, partners with global pharma, biotech and NFP organisations.
Since 2004, Sygnature Discovery has delivered over 56 novel pre-clinical and 35 clinical compounds, with its scientists named on over 225 patents. Therapeutic areas of expertise include oncology, inflammation and immunology, neuroscience, metabolic diseases, infectious diseases, and more. To find out more, please visit www.sygnaturediscovery.com.
About the role
As part of our continued growth at Sygnature Discovery, we’re recruiting an experienced VP of Metabolic Diseases and/or Immunology & Inflammation to join our Therapeutics teameither in Nottingham or Montreal. This role is hybrid/remote.
We’re looking for an expert with a proven track record of advancing drug candidates into human clinical trials, supported by an extensive publication and/or patent record. You will already be recognised as a key opinion leader in your field, with a strong reputation and established network.
You’ll bring a solid understanding of the CRO environment, whether gained through direct CRO experience or significant outsourcing exposure. Acting as a brand ambassador, you’ll promote our science both internally and externally, working closely with business development and commercial teams to identify and secure new opportunities. You’ll contribute to client meetings, proposals, and contracts, bringing scientific leadership and insight to the forefront.
Strong commercial acumen, alongside excellent communication and negotiation skills, will be key in helping to drive and elevate our drug discovery programmes.
Given the nature of this role, travel will be required for client meetings, conferences, and team engagement across sites.
If you’re ready to join a growing CRO and want to apply your breadth and depth of experience to shape the future of drug discovery- we’d love to hear from you.
